Emergent-Valneva Zika vaccine clears early trial
A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news